Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
9157 | 1182 | 33.8 | 53% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
5 | 4 | CHEMISTRY, ORGANIC//CHEMISTRY, INORGANIC & NUCLEAR//CHEMISTRY, MULTIDISCIPLINARY | 1745167 |
346 | 3 | CARDIOTOXICITY//ANTHRACYCLINES//CAMPTOTHECIN | 36072 |
1654 | 2 | DISTAMYCIN//MINOR GROOVE BINDER//PYRROLE IMIDAZOLE POLYAMIDE | 6885 |
9157 | 1 | SABARUBICIN//BARMINOMYCIN//ACTINOMYCIN | 1182 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | SABARUBICIN | authKW | 183693 | 1% | 89% | 8 |
2 | BARMINOMYCIN | authKW | 103328 | 0% | 100% | 4 |
3 | ACTINOMYCIN | authKW | 82350 | 1% | 25% | 13 |
4 | DAUNOMYCIN | authKW | 81788 | 2% | 14% | 23 |
5 | DOXOFORM | authKW | 77496 | 0% | 100% | 3 |
6 | FORMALDEHYDE ACTIVATION | authKW | 58121 | 0% | 75% | 3 |
7 | STUDIA BIOPHYSICA | journal | 55741 | 5% | 3% | 64 |
8 | ANTHRACYCLINE DISACCHARIDES | authKW | 51664 | 0% | 100% | 2 |
9 | FORMALDEHYDE RELEASING PRODRUGS | authKW | 51664 | 0% | 100% | 2 |
10 | METAL ACRIDINES | authKW | 51664 | 0% | 100% | 2 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Biophysics | 4889 | 24% | 0% | 281 |
2 | Biochemistry & Molecular Biology | 4194 | 50% | 0% | 588 |
3 | Chemistry, Medicinal | 783 | 8% | 0% | 98 |
4 | Pharmacology & Pharmacy | 296 | 12% | 0% | 138 |
5 | Chemistry, Multidisciplinary | 187 | 11% | 0% | 131 |
6 | Chemistry, Physical | 112 | 10% | 0% | 115 |
7 | Chemistry, Organic | 83 | 5% | 0% | 65 |
8 | Biochemical Research Methods | 61 | 3% | 0% | 40 |
9 | Oncology | 60 | 6% | 0% | 70 |
10 | Spectroscopy | 54 | 3% | 0% | 30 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ONCOL CHEM CORE TECHNOL | 51664 | 0% | 100% | 2 |
2 | AEG CREA | 25832 | 0% | 100% | 1 |
3 | BERBECK | 25832 | 0% | 100% | 1 |
4 | BIOMOLEC STRUCT UNIT CANC CAMPAIGN | 25832 | 0% | 100% | 1 |
5 | BIOORGAN UNIT | 25832 | 0% | 100% | 1 |
6 | BIOSECIENCES BIOMED ENGN | 25832 | 0% | 100% | 1 |
7 | CINESE SCI | 25832 | 0% | 100% | 1 |
8 | CLAUDE FREJACQUESDSMDRECAMSCM | 25832 | 0% | 100% | 1 |
9 | CLIN STUDY ANTICANCER MOL TARGETED DRUGS | 25832 | 0% | 100% | 1 |
10 | IND ENVIRONM BIOTECHNOL GRP | 25832 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | STUDIA BIOPHYSICA | 55741 | 5% | 3% | 64 |
2 | BIOPOLYMERS | 15732 | 5% | 1% | 63 |
3 | JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS | 14490 | 4% | 1% | 42 |
4 | ANTI-CANCER DRUG DESIGN | 11874 | 1% | 3% | 17 |
5 | BIOCHEMISTRY | 5448 | 9% | 0% | 107 |
6 | NUCLEIC ACIDS RESEARCH | 2677 | 5% | 0% | 65 |
7 | MOLECULAR BIOLOGY | 1957 | 2% | 0% | 19 |
8 | BIOFIZIKA | 1758 | 1% | 0% | 17 |
9 | ADVANCES IN PHARMACOLOGY AND CHEMOTHERAPY | 1433 | 0% | 6% | 1 |
10 | BIOPHYSICAL CHEMISTRY | 1346 | 1% | 0% | 15 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | SABARUBICIN | 183693 | 1% | 89% | 8 | Search SABARUBICIN | Search SABARUBICIN |
2 | BARMINOMYCIN | 103328 | 0% | 100% | 4 | Search BARMINOMYCIN | Search BARMINOMYCIN |
3 | ACTINOMYCIN | 82350 | 1% | 25% | 13 | Search ACTINOMYCIN | Search ACTINOMYCIN |
4 | DAUNOMYCIN | 81788 | 2% | 14% | 23 | Search DAUNOMYCIN | Search DAUNOMYCIN |
5 | DOXOFORM | 77496 | 0% | 100% | 3 | Search DOXOFORM | Search DOXOFORM |
6 | FORMALDEHYDE ACTIVATION | 58121 | 0% | 75% | 3 | Search FORMALDEHYDE+ACTIVATION | Search FORMALDEHYDE+ACTIVATION |
7 | ANTHRACYCLINE DISACCHARIDES | 51664 | 0% | 100% | 2 | Search ANTHRACYCLINE+DISACCHARIDES | Search ANTHRACYCLINE+DISACCHARIDES |
8 | FORMALDEHYDE RELEASING PRODRUGS | 51664 | 0% | 100% | 2 | Search FORMALDEHYDE+RELEASING+PRODRUGS | Search FORMALDEHYDE+RELEASING+PRODRUGS |
9 | METAL ACRIDINES | 51664 | 0% | 100% | 2 | Search METAL+ACRIDINES | Search METAL+ACRIDINES |
10 | RESTRICTION INHIBITION ASSAY RIA | 51664 | 0% | 100% | 2 | Search RESTRICTION+INHIBITION+ASSAY+RIA | Search RESTRICTION+INHIBITION+ASSAY+RIA |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | KIMURA, K , SPENCER, DMS , BILARDI, R , SWIFT, LP , BOX, AJ , BROWNLEE, RTC , CUTTS, SM , PHILLIPS, DR , (2010) BARMINOMYCIN, A MODEL FOR THE DEVELOPMENT OF NEW ANTHRACYCLINES.ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY. VOL. 10. ISSUE 1. P. 70-77 | 35 | 85% | 1 |
2 | BARTHWAL, R , SHARMA, U , SNIVASTAVA, N , JAIN, M , AWASTHI, P , KAUR, M , BARTHWAL, SK , GOVIL, G , (2006) STRUCTURE OF DAUNOMYCIN COMPLEXED TO D-TGATCA BY TWO-DIMENSIONAL NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY.EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY. VOL. 41. ISSUE 1. P. 27-39 | 33 | 85% | 6 |
3 | CUTTS, SM , REPHAELI, A , NUDELMAN, A , UGARENKO, M , PHILLIPS, DR , (2015) POTENTIAL THERAPEUTIC ADVANTAGES OF DOXORUBICIN WHEN ACTIVATED BY FORMALDEHYDE TO FUNCTION AS A DNA ADDUCT-FORMING AGENT.CURRENT TOPICS IN MEDICINAL CHEMISTRY. VOL. 15. ISSUE 14. P. 1409 -1422 | 45 | 49% | 0 |
4 | AGRAWAL, P , BARTHWAL, SK , GOVIL, G , BARTHWAL, R , (2009) STUDIES ON THE INTERACTION OF ADRIAMYCIN WITH D-(TGATCA)(2) BY PROTON NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY, TIME-RESOLVED FLUORESCENCE MEASUREMENT, DIFFUSION ORDERED SPECTROSCOPY FOLLOWED BY STRUCTURAL REFINEMENT USING RESTRAINED MOLECULAR DYNAMICS APPROACH.JOURNAL OF MOLECULAR STRUCTURE. VOL. 932. ISSUE 1-3. P. 67-83 | 26 | 81% | 1 |
5 | CUTTS, SM , NUDELMAN, A , REPHAELI, A , PHILLIPS, DR , (2005) THE POWER AND POTENTIAL OF DOXORUBICIN-DNA ADDUCTS.IUBMB LIFE. VOL. 57. ISSUE 2. P. 73 -81 | 29 | 67% | 72 |
6 | BIVER, T , VENTURINI, M , JARES-ERIJMAN, EA , JOVIN, TM , SECCO, F , (2009) 7-AMINOACTINOMYCIN BINDING TO DNA SEQUENCES LACKING GPC SITES: A THERMODYNAMIC AND KINETIC STUDY.BIOCHEMISTRY. VOL. 48. ISSUE 1. P. 173-179 | 22 | 88% | 3 |
7 | DOUGHTY, B , RAO, Y , KAZER, SW , KWOK, SJJ , TURRO, NJ , EISENTHAL, KB , (2013) BINDING OF THE ANTI-CANCER DRUG DAUNOMYCIN TO DNA PROBED BY SECOND HARMONIC GENERATION.JOURNAL OF PHYSICAL CHEMISTRY B. VOL. 117. ISSUE 49. P. 15285-15289 | 31 | 53% | 10 |
8 | AGRAWAL, P , BARTHWAL, SK , GOVIL, G , BARTHWAL, R , (2009) SOLUTION STUDIES ON THE COMPLEX OF 4 '-EPIADRIAMYCIN-D-(CGATCG)(2) FOLLOWED BY TIME-RESOLVED FLUORESCENCE MEASUREMENT, DIFFUSION ORDERED SPECTROSCOPY AND RESTRAINED MOLECULAR DYNAMICS SIMULATIONS.BIOORGANIC & MEDICINAL CHEMISTRY. VOL. 17. ISSUE 7. P. 2793-2811 | 24 | 75% | 0 |
9 | MUKHERJEE, A , SASIKALA, WD , (2013) DRUG-DNA INTERCALATION: FROM DISCOVERY TO THE MOLECULAR MECHANISM.DYNAMICS OF PROTEINS AND NUCLEIC ACIDS. VOL. 92. ISSUE . P. 1 -62 | 40 | 35% | 14 |
10 | ZHU, SH , YAN, LM , JI, XB , LU, WC , (2010) CONFORMATIONAL DIVERSITY OF ANTHRACYCLINE ANTICANCER ANTIBIOTICS: A DENSITY FUNCTIONAL THEORY CALCULATION.JOURNAL OF MOLECULAR STRUCTURE-THEOCHEM. VOL. 951. ISSUE 1-3. P. 60 -68 | 34 | 47% | 3 |
Classes with closest relation at Level 1 |